Indirab Vaccine B.P 0.5ML is primarily indicated in conditions like Neuroparalytic complications associated with the nervous tissue vaccines., Post-exposure prophylaxis, Pre-exposure prophylaxis.
The symptomatic adverse reactions produced by Indirab Vaccine B.P 0.5ML are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Hypersensitivity reactions, Itching, Local pain, Malaise, Gastrointestinal disturbances.
No data regarding the contra indications of Indirab Vaccine B.P 0.5ML is available.
Health staff must be well trained in techniques and vaccines must be stored appropriately for effectiveness. WHO recommends that toddlers and children in highly endemic areas may also be considered for rabies pre exposure vaccination.